Feed Insights Top Reports Pricing

⌘K

08:15:09·403d

ANALYSTRatingvia Quantisnow

Oppenheimer initiated coverage on WEX

ByQuantisnow·Wall Street's wire, on your screen.

Real Estate

Plus alert sent

Quantisnow Plus members were alerted at 08:15:09 ET - 0.9s after publication.

Sign up for Plus

Free Quantisnow account

Get notified the moment WEX files

Real-time alerts on SEC filings, FDA approvals, analyst ratings, insider trades, and press releases. Follow any ticker. No credit card.

Sign up free Log in

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WEX (WEX Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Related

COO, Amer. Payments & Mobility Carriedo Carlos covered exercise/tax liability with 174 shares and converted options into 391 shares, increasing direct ownership by 2% to 12,151 units (SEC Form 4)
Chief Legal Officer Trickett Sara converted options into 173 units of Common Stock and covered exercise/tax liability with 52 units of Common Stock, increasing direct ownership by 3% to 3,595 units (SEC Form 4)
WEX® Recognized by Forbes as One of America's Best Employers for Company Culture 2026
COO, Benefits Deshaies Robert Joseph sold $173,808 worth of shares (1,200 units at $144.84), decreasing direct ownership by 5% to 22,288 units (SEC Form 4)
Director Groch James R bought $214,425 worth of shares (1,500 units at $142.95), increasing direct ownership by 9% to 17,957 units (SEC Form 4)

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022